# Senti Biosciences Holdings, Inc.: Form SCHEDULE 13D/A, filed Sep 2, 2025

- Company: [Senti Biosciences Holdings, Inc.](/companies/snti.md) (CIK 1854270)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-02
- Accepted by EDGAR: Sep 2, 2025, 08:15 ET
- Period: not reported
- Accession: 0000902664-25-003924
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1854270/000090266425003924/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1854270/000090266425003924/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1854270/000090266425003924/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-003924. Last ingested by Listed: Oct 27, 2026, 16:38 ET. No prices; not investment advice.